INTEGRAL AD SCIENCE

IAS
Delayed Nasdaq - 01:00 2022-11-25 pm EST
9.660 USD -2.33%
Valuation
Fiscal Period: December 2021 2022
Capitalization1 3 4191 486
Enterprise Value (EV)1 3 5891 642
P/E ratio -60,0x211x
Yield --
Capitalization / Revenue 10,6x3,70x
EV / Revenue 11,1x4,09x
EV / EBITDA 34,7x13,4x
Price to Book 4,16x1,96x
Nbr of stocks (in thousands) 153 941153 828
Reference price (USD) 22,29,66
Announcement Date 03/03/2022-
Previous period Next period
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2021 2022
Net sales1 324402
EBITDA1 103123
Operating profit (EBIT)1 -33,018,0
Operating Margin -10,2%4,48%
Pre-Tax Profit (EBT)1 -56,013,4
Net income1 -52,46,98
Net margin -16,2%1,74%
EPS2 -0,370,05
Dividend per Share --
Announcement Date 03/03/2022-
Previous period Next period
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2021 2022
Net Debt1 170156
Net Cash position1 --
Leverage (Debt / EBITDA) 1,64x1,28x
Free Cash Flow1 62,661,0
ROE (Net Profit / Equities) -8,75%0,58%
Shareholders' equity1 5991 204
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share2 5,344,94
Cash Flow per Share 0,44-
Capex1 0,9615,0
Capex / Sales 0,30%3,73%
Announcement Date 03/03/2022-
Previous period Next period
1 USD in Million
2 USD
Estimates
Financial Ratios
Size 2022e 2023e
Capitalization 1 486 M $ -
Enterprise Value (EV) 1 642 M $ 1 560 M $
Valuation 2022e 2023e
P/E ratio (Price / EPS) 211x 66,6x
Capitalization / Revenue 3,70x 3,20x
EV / Revenue 4,09x 3,54x
EV / EBITDA 13,4x 11,3x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,96x 1,88x
Profitability 2022e 2023e
Operating Margin (EBIT / Sales) 4,48% 9,62%
Operating Leverage (Delta EBIT / Delta Sales) 6,37x 9,53x
Net Margin (Net Profit / Revenue) 1,74% 4,92%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 0,58% 3,11%
Rate of Dividend - -
Balance Sheet Analysis 2022e 2023e
CAPEX / Sales   3,73% 3,66%
Cash Flow / CA - -
Capital Intensity (Assets / Revenue) - -
Financial Leverage (Net Debt / EBITDA) 1,28x 0,51x
Price Earning Ratio
Change in Enterprise Value/EBITDA
EPS & Dividend